Offer - Urjas Oil for just ₹ 1
Mabtas T 100 Injection is a prescription drug, available for use as Injection. Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia are some of its major therapeutic uses. Secondary and off-label uses of Mabtas T 100 Injection have also been mentioned below.
The optimal dosage of Mabtas T 100 Injection is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Mabtas T 100 Injection are Weakness. Besides the aforementioned side effects, there are other adverse effects of Mabtas T 100 Injection as well, which are listed below. Normally, these side effects of Mabtas T 100 Injection are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Mabtas T 100 Injection's effect is Moderate during pregnancy and Severe for lactating mothers. Warnings related to Mabtas T 100 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Hyperkalemia must refrain from the use of Mabtas T 100 Injection since this can cause severe adverse effects. Other contraindications of Mabtas T 100 Injection have been discussed in the sections ahead.
Drug interactions for Mabtas T 100 Injection have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Mabtas T 100 Injection is not safe while driving, and is not addiction.
Mabtas T 100 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Mabtas T 100 Injection safe for pregnant women?
Pregnant women may experience moderate side effects from Mabtas T. It is best to stop taking Mabtas T immediately and inform your doctor if you notice any discomfort.
Is the use of Mabtas T 100 Injection safe during breastfeeding?
Taking Mabtas T may lead to serious side effects if you are breastfeeding. Mabtas T should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Mabtas T 100 Injection on the Kidneys?
Mabtas T can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Mabtas T 100 Injection on the Liver?
Using Mabtas T does not have any harmful effects on the liver.
What is the effect of Mabtas T 100 Injection on the Heart?
The heart can be affected by Mabtas T. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Mabtas T 100 Injection unless your doctor advises you to do so -
Is this Mabtas T 100 Injection habit forming or addictive?
Mabtas T 100 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Mabtas T 100 Injection. So it is best to avoid driving.
Is it safe?
Mabtas T 100 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Mabtas T 100 Injection cannot treat any kind of mental disorder.
Interaction between Food and Mabtas T 100 Injection
You can take Mabtas T 100 Injection with food.
Interaction between Alcohol and Mabtas T 100 Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Mabtas T 100 Injection.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872